Login
Toggle navigation
Videos
Categories
Trending
Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ben McMillan, CIO of IDX Digital Assets,
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Expert alert: Four ways organ transplants are being transformed to save more lives - Julie K. Heimbach, M.D. General Surgeon, Mayo Clinic
00:10:00
Accelerating Electric Vehicle Adoption: Challenges and Imperatives for New Zealand |Fraser Whineray, CEO, Mercury Nz Ltd.
00:10:00
Christian Stendevad , CEO of Penneo outlines the company's European growth strategy, emphasizing digital solutions for client processes and KYC compliance.
00:10:00
El Al Israel Airlines Ltd. CEO Interview
00:10:00
Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare
00:00:00
Jesús Martin-Garcia, Chief Executive Officer, Geneuro
00:10:00
Pioneering Scandinavian Mining: Sir Percy Minerals' Path to Production and Innovation
00:00:00
At 81, woman is among world’s longest-surviving transplant recipients - Dr. Thomas R. Schwab, Mayo Clinic
00:10:00
Chairman Gao Xinming of Marketech International Corp. (MIC) shared insights on "soft power conquering the world" at the Women's CEO Forum today.
00:10:00
Adrian Goldfarb, CFO of Duos Technologies Group, Inc. (OTCQB: DUOT), discusses the company's progress at the OTCQB Executive Forum with SNNLive..|Charles (Chuck) Ferry is Chief Executive Officer of Duos Technologies Group Inc
00:10:00
Gavin Nixon Highlights Arafura Resources' Development of the Nolans Project
00:10:00
An engaged and experienced Board of Directors can help guide a company to success|David Motley,General Partner,Black Tech Nation Ventures